Press release
Global Renal Anemia Treatment Market 2023: Development of Novel HIF Stabilizers & Approval of Cost-effective Biosimilar Drugs Expected to Push Growth
The renal anemia treatment market refers to the industry that produces and sells drugs and therapies used to treat anemia caused by chronic kidney disease (CKD). Renal anemia is a common complication of CKD and is characterized by a decrease in red blood cells caused by a deficiency in erythropoietin (EPO) production. The market for renal anemia treatment is expected to grow due to the increasing prevalence of CKD and the aging population. The market is dominated by erythropoiesis-stimulating agents (ESAs) such as Epogen (epoetin alfa) and Procrit (epoetin alfa) which are used to increase the production of red blood cells in patients with renal anemia. These drugs are typically administered in conjunction with iron supplements to increase iron stores in the body. However, the high cost of treatment and the potential side effects associated with ESAs may limit market growth.Request For Free Sample Report of "Renal Anemia Treatment Market"@ https://www.persistencemarketresearch.com/samples/27115
Renal Anemia Treatment Market: Key Dynamics
The global burden of chronic kidney disease continues to increase throughout the globe, which is driving the growth of the renal anemia treatment market. According to the National Kidney Foundation, 10% of the population worldwide is affected by the chronic kidney disease (CKD), which in turn, has increased the patient pool for renal anemia treatment. Increasing cases of chronic kidney disease and increasing prevalence of diabetes and hyper tension will push the market of renal anemia treatment in near future.
Additionally, the development and identification of novel HIF stabilizers is likely to change the pathway for renal anemia treatment in near future. HIF stabilizers under clinical trial hold promise as they provide a unique modality for renal anemia treatment through novel mechanisms of action. There are currently 4 HIF stabilizers that are in phase 2/3 clinical trials (roxadustat, daprodustat, vadadustat, and molidustat) and all of these are orally administered agents which will create huge opportunities for the growth of the renal anemia treatment market during the forecast period.
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/27115
Companies
Amgen Inc.
Vifor Pharma Management Ltd.
Hoffmann-La Roche Ltd
Pfizer Inc.
Sandoz International GmbH (Novartis AG)
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
On the other side, drugs for renal anemia treatment come with a huge price tag. Even the good health insurance benefits do not necessarily cover biologics and thus, the out-of-pocket expenditure is too high. High cost for renal anemia treatment is, thus, the biggest factor that limits the treatment seeking rate with biologics and in turn, negatively impacts the growth of the renal anemia treatment market. Moreover, long-term renal anemia treatment with erythropoiesis-stimulating agents (ESAs) has been associated with increased systemic blood pressure and occurrence of seizures.
Hypertension is a common side effect of intravenous use of erythropoiesis-stimulating agents. A significant side effect of erythropoiesis-stimulating agents is increased risk of thromboembolic complications. Also, in patients with cancer, erythropoiesis-stimulating agents cause the tumor to grow. Therefore, the many side effects associated with the use of erythropoiesis-stimulating agents might hinder the growth of the renal anemia treatment market in the near future.
Erythrocyte stimulating agents and iron supplements are used in combination for renal anemia treatment. Among both product types, erythrocyte stimulating agents are estimated to gain major market revenue share in the global renal anemia treatment market due to their high price tag. The drugs for renal anemia treatment are available in both oral and injectable forms in the market. However, the injectable drugs are more preferred by doctors for renal anemia treatment and hence, by route of administration, the parenteral segment holds the majority share of the global renal anemia treatment market, in terms of revenue.
Among all distribution channels, the hospital pharmacies segment is expected to be most dominant segment in global renal anemia treatment market and will be followed by retail pharmacies. The mail order pharmacies segment is expected grow at a fast pace in the renal anemia treatment market.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/27115
Key Questions Answered in This Report.
What are the Roadblocks for Renal Anemia Treatment Market Suppliers?
What are the Key Opportunities for Renal Anemia Treatment Market Manufacturers?
How is Focus on Safety Influencing Renal Anemia Treatment Market Demand?
What is the Regulatory Impact on Global Sales of Renal Anemia Treatment Market?
Which Region Offers the Largest Opportunity for Sales of Renal Anemia Treatment Market?
Where Does the U.S. Stand in the Market for Renal Anemia Treatment Market?
What Is the Outlook for Renal Anemia Treatment Market Manufacturers in China?
Why is Germany a Lucrative Market for Renal Anemia Treatment Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Renal Anemia Treatment Market?
Why is There High Demand for Tires in Renal Anemia Treatment Market?
Why are Sales of Renal Anemia Treatment Market Surging?
Related Market Research Reports:
Autogenous Vaccine For Aquaculture Market: https://www.persistencemarketresearch.com/market-research/autogenous-vaccine-for-aquaculture-market.asp
Intravitreal (IVT) Injectable Market: https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp
Primary Hepatocytes Market: https://www.persistencemarketresearch.com/market-research/primary-hepatocytes-market.asp
Oncology Mice Models Market: https://www.prnewswire.com/news-releases/oncology-mice-models-market-with-an-estimated-growth-rate-of-6-over-the-decade-persistence-market-research-301531935.html
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Renal Anemia Treatment Market 2023: Development of Novel HIF Stabilizers & Approval of Cost-effective Biosimilar Drugs Expected to Push Growth here
News-ID: 3014835 • Views: …
More Releases from Persistence Market Research

Crypto Asset Management Market Expected to Register USD 2.28 Billion Revenue by …
The crypto asset management market is emerging as a crucial segment within the financial technology and blockchain ecosystem, providing secure, transparent, and efficient solutions for managing digital assets. Crypto asset management platforms enable institutional and retail investors to track, trade, and optimize cryptocurrency portfolios, leveraging technologies like artificial intelligence (AI) and machine learning (ML) for enhanced decision-making and transaction efficiency. The increasing adoption of cryptocurrencies, coupled with regulatory clarity in…

Multi-Vendor Support Services Industry Poised for Growth at 3.2% CAGR Through 20 …
The multi-vendor support services market is emerging as a critical component in enterprise IT management, helping organizations efficiently manage complex IT environments across multiple hardware and software vendors. These services provide consolidated support, maintenance, and management for diverse IT assets, reducing operational downtime and improving cost efficiency. With the increasing adoption of hybrid and multi-cloud strategies, enterprises require expert support to navigate interoperability challenges, optimize vendor relationships, and ensure seamless…

Global Neuromorphic Computing Industry Anticipated to Reach USD 20.4 Billion by …
The neuromorphic computing market is emerging as a transformative segment within the broader artificial intelligence (AI) and computing industry. Neuromorphic computing mimics the human brain's neural architecture, enabling machines to process information more efficiently and with lower energy consumption than traditional computing systems. This technology finds applications in robotics, autonomous vehicles, healthcare diagnostics, cybersecurity, and consumer electronics, making it a versatile and high-growth area. As the demand for AI-driven automation…

Anime Merchandising Market Expected to Register USD 18.16 Billion Revenue by 203 …
The global anime merchandising market has witnessed remarkable growth in recent years, driven by the worldwide popularity of anime content and increasing fan engagement. Merchandise provides fans with tangible ways to express their fandom, ranging from toys and figurines to apparel, accessories, and lifestyle products. The proliferation of e-commerce platforms and specialized online stores has further enhanced accessibility, allowing enthusiasts from different regions to purchase exclusive, limited-edition items. Collaborations with…
More Releases for Renal
Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market?
The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors…
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032.
Renal Osteodystrophy Market Overview
The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early…
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development…
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…